K. Dickson et al., SPECIFIC BINDING OF ENDOCRINE TRANSFORMING GROWTH-FACTOR-BETA-1 TO VASCULAR ENDOTHELIUM, The Journal of clinical investigation, 95(6), 1995, pp. 2539-2554
The presentation of recombinant biologically active I-125-TGF-beta 1 v
ia the bloodstream to potential target cells in mice and rats was eval
uated by quantitative light and electron microscope radioautography, S
pecificity was evaluated by in vivo competition with excess unlabeled
TGF-beta 1, and integrity of the ligand at the binding site was demons
trated by trichloroacetic acid precipitation after extraction from tis
sues, The distribution of radiolabel at 2.5, 15, 30, 45, and 60 min af
ter I-125-TGF-beta 1 injection revealed radiolabel principally over mi
crovasculature endothelium but at times > 2.5 min over endothelial end
ocytic components indicative of internalization. Nonspecific binding o
f I-125-TGF-beta 1 to the apex of the proximal convoluted tubule of th
e kidney indicated it as the likely site of rapid clearance of TGF-bet
a 1 from the circulation, while a comparison of the binding of I-125-T
GF-beta 1 (endothelial) to that of I-125-TGF-beta 1 complexed with alp
ha(2)-macroglobulin-methylamine (liver parenchyma) indicated that clea
rance of TGF-beta 1 complexed alpha 2-macroglobulin was likely via the
hepatic alpha 2-macroglobulin receptor. The endothelial TGF-beta rece
ptors uncovered here are likely involved in the local regulatory mecha
nism of leukocyte and monocyte adhesion and tissue infiltration regula
ted by endocrine TGF-beta 1.